China Pharma (NYSE:CPHI) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI) in a research note released on Saturday. The brokerage issued a hold rating on the stock.

China Pharma Stock Performance

Shares of NYSE CPHI opened at $0.19 on Friday. The company’s 50-day simple moving average is $0.20 and its 200-day simple moving average is $0.22. The company has a current ratio of 0.79, a quick ratio of 0.26 and a debt-to-equity ratio of 0.22. China Pharma has a 52-week low of $0.13 and a 52-week high of $0.60.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.